Annual Mortality Related to Pulmonary Embolism in the U.S. Before and During the COVID-19 Pandemic

Ioannis T. Farmakis; Luca Valerio; Behnood Bikdeli; Jean M. Connors; George Giannakoulas; Samuel Z. Goldhaber; Lukas Hobohm; Beverley J. Hunt; Karsten Keller; Alex C. Spyropoulos; Stefano Barco

doi:10.1016/j.jacc.2022.08.721

Annual Mortality Related to Pulmonary Embolism in the U.S. Before and During the COVID-19 Pandemic

Ioannis T. Farmakis, Luca Valerio, Behnood Bikdeli, Jean M. Connors, George Giannakoulas, Samuel Z. Goldhaber, Lukas Hobohm, Beverley J. Hunt, Karsten Keller, Alex C. Spyropoulos, Stefano Barco

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Original language	English
Pages (from-to)	1579-1581
Number of pages	3
Journal	Journal of the American College of Cardiology
Volume	80
Issue number	16
DOIs	https://doi.org/10.1016/j.jacc.2022.08.721
State	Published - 18 Oct 2022
Externally published	Yes

Access to Document

10.1016/j.jacc.2022.08.721

Cite this

Farmakis, I. T., Valerio, L., Bikdeli, B., Connors, J. M., Giannakoulas, G., Goldhaber, S. Z., Hobohm, L., Hunt, B. J., Keller, K., Spyropoulos, A. C., & Barco, S. (2022). Annual Mortality Related to Pulmonary Embolism in the U.S. Before and During the COVID-19 Pandemic. Journal of the American College of Cardiology, 80(16), 1579-1581. https://doi.org/10.1016/j.jacc.2022.08.721

@article{17c2836e69ff4cc8b0f0c02fbaaa5cb6,

title = "Annual Mortality Related to Pulmonary Embolism in the U.S. Before and During the COVID-19 Pandemic",

author = "Farmakis, {Ioannis T.} and Luca Valerio and Behnood Bikdeli and Connors, {Jean M.} and George Giannakoulas and Goldhaber, {Samuel Z.} and Lukas Hobohm and Hunt, {Beverley J.} and Karsten Keller and Spyropoulos, {Alex C.} and Stefano Barco",

note = "Funding Information: Dr Bikdeli is supported by the IGNITE Award from the Mary Horrigan Connors Center for Women{\textquoteright}s Health and Gender Biology at Brigham and Women{\textquoteright}s Hospital and a Career Development Award from the American Heart Association; and has served as a consulting expert, on behalf of the plaintiff, for litigation related to 2 specific brand models of inferior vena cava filters. Dr Connors has received personal fees for scientific advisory boards and consulting from Abbott, Anthos, Alnylam, Bristol Myers Squibb, Five Prime Therapeutics, Pfizer, and Takeda; and has received research funding from CSL Behring. Dr Giannakoulas has received lecture/consultant fees from Bayer HealthCare, Pfizer, and LeoPharma. Dr Hobohm has received lecture/consultant fees from MSD and Actelion, outside the submitted work. Dr Barco has received lecture/consultant fees from Bayer HealthCare, Concept Medical, BTG Pharmaceuticals, INARI, Boston Scientific, and LeoPharma; has received institutional grants from Boston Scientific, Bentley, Bayer HealthCare, INARI, Medtronic, Concept Medical, Bard, and Sanofi; and has received economical support for travel/congress costs from Daiichi-Sankyo, BTG Pharmaceuticals, and Bayer HealthCare, outside the submitted work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: Dr Bikdeli is supported by the IGNITE Award from the Mary Horrigan Connors Center for Women's Health and Gender Biology at Brigham and Women's Hospital and a Career Development Award from the American Heart Association; and has served as a consulting expert, on behalf of the plaintiff, for litigation related to 2 specific brand models of inferior vena cava filters. Dr Connors has received personal fees for scientific advisory boards and consulting from Abbott, Anthos, Alnylam, Bristol Myers Squibb, Five Prime Therapeutics, Pfizer, and Takeda; and has received research funding from CSL Behring. Dr Giannakoulas has received lecture/consultant fees from Bayer HealthCare, Pfizer, and LeoPharma. Dr Hobohm has received lecture/consultant fees from MSD and Actelion, outside the submitted work. Dr Barco has received lecture/consultant fees from Bayer HealthCare, Concept Medical, BTG Pharmaceuticals, INARI, Boston Scientific, and LeoPharma; has received institutional grants from Boston Scientific, Bentley, Bayer HealthCare, INARI, Medtronic, Concept Medical, Bard, and Sanofi; and has received economical support for travel/congress costs from Daiichi-Sankyo, BTG Pharmaceuticals, and Bayer HealthCare, outside the submitted work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.",

year = "2022",

month = oct,

day = "18",

doi = "10.1016/j.jacc.2022.08.721",

language = "English",

volume = "80",

pages = "1579--1581",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier USA",

number = "16",

}

Farmakis, IT, Valerio, L, Bikdeli, B, Connors, JM, Giannakoulas, G, Goldhaber, SZ, Hobohm, L, Hunt, BJ, Keller, K, Spyropoulos, AC & Barco, S 2022, 'Annual Mortality Related to Pulmonary Embolism in the U.S. Before and During the COVID-19 Pandemic', Journal of the American College of Cardiology, vol. 80, no. 16, pp. 1579-1581. https://doi.org/10.1016/j.jacc.2022.08.721

TY - JOUR

T1 - Annual Mortality Related to Pulmonary Embolism in the U.S. Before and During the COVID-19 Pandemic

AU - Farmakis, Ioannis T.

AU - Valerio, Luca

AU - Bikdeli, Behnood

AU - Connors, Jean M.

AU - Giannakoulas, George

AU - Goldhaber, Samuel Z.

AU - Hobohm, Lukas

AU - Hunt, Beverley J.

AU - Keller, Karsten

AU - Spyropoulos, Alex C.

AU - Barco, Stefano

N1 - Funding Information: Dr Bikdeli is supported by the IGNITE Award from the Mary Horrigan Connors Center for Women’s Health and Gender Biology at Brigham and Women’s Hospital and a Career Development Award from the American Heart Association; and has served as a consulting expert, on behalf of the plaintiff, for litigation related to 2 specific brand models of inferior vena cava filters. Dr Connors has received personal fees for scientific advisory boards and consulting from Abbott, Anthos, Alnylam, Bristol Myers Squibb, Five Prime Therapeutics, Pfizer, and Takeda; and has received research funding from CSL Behring. Dr Giannakoulas has received lecture/consultant fees from Bayer HealthCare, Pfizer, and LeoPharma. Dr Hobohm has received lecture/consultant fees from MSD and Actelion, outside the submitted work. Dr Barco has received lecture/consultant fees from Bayer HealthCare, Concept Medical, BTG Pharmaceuticals, INARI, Boston Scientific, and LeoPharma; has received institutional grants from Boston Scientific, Bentley, Bayer HealthCare, INARI, Medtronic, Concept Medical, Bard, and Sanofi; and has received economical support for travel/congress costs from Daiichi-Sankyo, BTG Pharmaceuticals, and Bayer HealthCare, outside the submitted work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: Dr Bikdeli is supported by the IGNITE Award from the Mary Horrigan Connors Center for Women's Health and Gender Biology at Brigham and Women's Hospital and a Career Development Award from the American Heart Association; and has served as a consulting expert, on behalf of the plaintiff, for litigation related to 2 specific brand models of inferior vena cava filters. Dr Connors has received personal fees for scientific advisory boards and consulting from Abbott, Anthos, Alnylam, Bristol Myers Squibb, Five Prime Therapeutics, Pfizer, and Takeda; and has received research funding from CSL Behring. Dr Giannakoulas has received lecture/consultant fees from Bayer HealthCare, Pfizer, and LeoPharma. Dr Hobohm has received lecture/consultant fees from MSD and Actelion, outside the submitted work. Dr Barco has received lecture/consultant fees from Bayer HealthCare, Concept Medical, BTG Pharmaceuticals, INARI, Boston Scientific, and LeoPharma; has received institutional grants from Boston Scientific, Bentley, Bayer HealthCare, INARI, Medtronic, Concept Medical, Bard, and Sanofi; and has received economical support for travel/congress costs from Daiichi-Sankyo, BTG Pharmaceuticals, and Bayer HealthCare, outside the submitted work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

PY - 2022/10/18

Y1 - 2022/10/18

UR - http://www.scopus.com/inward/record.url?scp=85139045629&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2022.08.721

DO - 10.1016/j.jacc.2022.08.721

M3 - Letter

C2 - 36038034

AN - SCOPUS:85139045629

SN - 0735-1097

VL - 80

SP - 1579

EP - 1581

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 16

ER -